Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Kodak: Over-Exposed

Published 08/11/2020, 12:36 AM
Updated 07/09/2023, 06:31 AM

In one of the most bizarre announcements in corporate history, ailing has-been Eastman Kodak (NYSE:KODK) a gem of a company decades ago but basically a shell of its former self now was suddenly awarded a nearly billion-dollar loan from the men of D.C., to develop a COVID vaccine. Naturally, their nearly-worthless stock exploded thousands of percent higher in value.

In the only example over the past decade of crime being taken seriously, the government actually is having second thoughts about handing a gargantuan sum of money to some less-than-savory characters, thus:

Tweet

Of course, retail bagholders have been taken on a wild ride. A stock that basically no one traded and was dragging around at almost $zero was thrust upward to $60 and has had almost all those gains beaten out of it already in a matter of days.

Kodak Share Price

 

See, the execs at Kodak didn’t do a crackerjack job hiding their tracks. The volume on KODK went from virtually nothing to over a quarter billion shares before the announcement even rolled out. And, naturally, the volume has been quite high ever since, as the stock has proceeded to lose virtually all of its value once more.

Kodak Share Valuation

This isn’t the first time Kodak has a pulled a “THIS will save the company, men!” stunt. The last one, pathetically, was when they jumped aboard the crypto train during the Altucher Peak. This two yellow tints mark the results of crypto (left side) and the Kodak Vaccine Fiasco (right side).

Kodak Chart

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Tim they were not awarded the funds to create a covid vaccine. rather to create generic drug compounds which is essential for the US since most generic drugs are made elsewhere.
I'm still waiting for this story to develop.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.